VEGF therapy: risky business for established plaques?
The mutational spectrum of type 1 von Willebrand disease: results from a Canadian cohort study

Prognostic significance of early vaso-occlusive complications in children with sickle cell anemia
The mutational spectrum of type 1 von Willebrand disease: results from a Canadian cohort study

The immunosuppressive drug FK778 induces regulatory activity in stimulated human CD4+CD25– T cells

VEGF therapy: risky business for established plaques?

T-lymphoid, megakaryocyte, and granulocyte development are sensitive to decreases in CBFß dosage.
STAT3 mediates hepatic hepcidin expression and its inflammatory stimulation
